Cargando…
Indirect Estimation of the Comparative Treatment Effect in Pharmacogenomic Subgroups
Evidence of clinical utility is a key issue in translating pharmacogenomics into clinical practice. Appropriately designed randomized controlled trials generally provide the most robust evidence of the clinical utility, but often only data from a pharmacogenomic association study are available. This...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3754999/ https://www.ncbi.nlm.nih.gov/pubmed/24015225 http://dx.doi.org/10.1371/journal.pone.0072256 |